首页> 外文期刊>Nuclear Medicine Communications >Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray.
【24h】

Altered gene expression profiles by sodium/iodide symporter gene transfection in a human anaplastic thyroid carcinoma cell line using a radioactive complementary DNA microarray.

机译:在人类间变性甲状腺癌癌细胞系中使用放射性互补DNA微阵列通过钠/碘转运体基因转染改变的基因表达谱。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The sodium/iodide symporter (NIS) is a membrane glycoprotein that mediates active 131I uptake during the treatment of cancer of the thyroid gland and extrathyroidal tissues. NIS gene transfection, a gene-therapy modality, has been introduced in many types of cancer, such as prostate cancer and breast cancer, and has demonstrated a high potential for the treatment of non-thyroidal cancers. AIM: To investigate the pattern of NIS gene expression and provide evidence of its beneficial effects in human anaplastic cancer ARO cells by using a radioactive complementary DNA (cDNA) microarray. METHODS: For cDNA microarray data analysis, superimposed images and clustergrams were prepared from basic radioactivity data obtained using a phosphoimager system. Gene expression profiles were constructed using the Z-transformed values of genes related to cancer biology. RESULTS: Radioactive cDNA microarray studies showed that 11 genes were upregulated (Z ratio > 1.5) and 31 genes were downregulated (Z ratio <-1.5) in response to NIS gene transfection. Of these differentially expressed genes, 33% were related to cell proliferation and apoptosis. Moreover, NIS gene transfection into an anaplastic thyroid cancer cell line affected the expression of the protein tyrosine phosphatase (PTP) family and Ras oncogene family, including Ras, Rac and Rab. CONCLUSION: The identification of changes in the patterns of gene expression may provide a better understanding of the response of molecular mechanisms to NIS gene transfection.
机译:背景:钠/碘离子转运蛋白(NIS)是一种膜糖蛋白,可在甲状腺和甲状腺外组织的癌症治疗过程中介导主动131I摄取。 NIS基因转染是一种基因治疗手段,已被引入许多类型的癌症中,例如前列腺癌和乳腺癌,并显示出治疗非甲状腺癌的巨大潜力。目的:通过使用放射性互补DNA(cDNA)微阵列,研究NIS基因表达的模式,并提供其对人间变性癌ARO细胞有益作用的证据。方法:对于cDNA微阵列数据分析,从使用phosphoimager系统获得的基本放射性数据制备了叠加图像和聚类图。使用与癌症生物学相关的基因的Z转换值构建基因表达谱。结果:放射性cDNA微阵列研究表明,响应NIS基因转染,有11个基因被上调(Z比> 1.5)和31个基因被下调(Z比<-1.5)。在这些差异表达的基因中,有33%与细胞增殖和凋亡有关。此外,NIS基因转染到变性甲状腺癌细胞系中会影响蛋白酪氨酸磷酸酶(PTP)家族和Ras癌基因家族(包括Ras,Rac和Rab)的表达。结论:鉴定基因表达模式的变化可以更好地理解分子机制对NIS基因转染的响应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号